Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Regulatory explorer
Regulatory document

FDA Notice: Comment Request on Dietary Supplement CGMP Information Collection

A US Federal Register notice from the FDA announces a 60-day public comment period on the proposed collection of information under its current good manufacturing practice regulations for dietary supplements. It is a notice, not a final rule, and does not determine compliance or current law. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The FDA announces a 60-day public comment period on a proposed information collection. [1]

  2. The notice solicits comments on the information collection provisions of the dietary supplement CGMP regulations. [1]

  3. The web rendition is informational, not the official legal edition. [1]

The source at a glance

Jurisdiction
US
Authority
Health and Human Services Department; Food and Drug Administration
Document type
Notice
Record type / format
Notice (Federal Register document record)
Scope / context
Dietary supplement manufacturers and other parties affected by FDA CGMP information collection provisions; public commenters.
Summary based on
Official regulatory document
Original publication
February 24, 2026

FDA notice on dietary supplement CGMP comment period

This is a notice from the US Department of Health and Human Services, Food and Drug Administration, published in the Federal Register on 2026-02-24. The agency announces an opportunity for public comment on a proposed collection of information. Under the Paperwork Reduction Act of 1995, federal agencies must publish notice of each proposed collection, including extensions of an existing collection, and allow 60 days for public comment. This notice solicits comments on the information collection provisions of FDA regulations on current good manufacturing practice for dietary supplements.

Supporting source [1]

What the notice covers and what it does not

The supplied text covers only the comment request on the information collection provisions of the dietary supplement CGMP regulations. It does not state the specific information being collected, the estimated burden, or any rule changes. The agency abstract notes that a proposed rule or notice is not a final rule, and that a publication date is not necessarily an effective date. The source alone does not determine a product's compliance or current legal status.

Supporting source [1]

Informational web rendition versus official legal edition

The web/API rendition is described as an informational resource, not the official legal edition. Readers are directed to verify the linked official PDF on GovInfo and applicable later amendments before relying on legal requirements. This is a document record, not a determination of current law, and it is not legal advice.

Supporting source [1]

How to interpret this

Document summary; not a determination of current law. Based only on the agency abstract and metadata; the full document was not reviewed. A notice is not a final rule, and a publication date is not necessarily an effective date.

Based on the cited official document. Its jurisdiction, document type and effective date matter; a proposal or notice is not a rule already in force.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    allow 60 days for public comment
  2. Finding 2 ↑

    information collection provisions of FDA's regulations
  3. Finding 3 ↑

    informational resource, not the official legal edition

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…